As a fully-serviced outsourcing partner, NextPharma will offer primary and secondary packaging solutions within the European territory.
MPE vice president Toshiaki Mikuni said, "We needed a partner with a significant European presence and we were also impressed by the packaging solutions available at NextPharma’s state-of-the-art, solids facility in Germany."
Launched already in Germany and Austria, BindRen is scheduled to be introduced in other countries shortly.
With a generic name as colestilan, the orally available non-absorbed anion exchange resin has been developed to treathyperphosphataemia in adult patients with Chronic Kidney Disease (CKD) Stage 5 receiving haemodialysis or peritoneal dialysis.